The global market for Fully Bioresorbable Stents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The material of the degradable stent is polylactic acid, etc., which can be completely degraded within 2-3 years after implantation in the body, and can restore the function and elasticity of blood vessels without permanent retention.

North American market for Fully Bioresorbable Stents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Fully Bioresorbable Stents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Fully Bioresorbable Stents include Abbott, Lepu Medical Technology, Shandong Hua'an Biotechnology, MicroPort, Lifetech Scientific, Beijing Advanced Medical Technologies, Shanghai Bio-heart Biological Technology, Elixir Medical Corporation, Biotronic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fully Bioresorbable Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fully Bioresorbable Stents.

The Fully Bioresorbable Stents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fully Bioresorbable Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fully Bioresorbable Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Fully Bioresorbable Stents Market Report

Report Metric	Details
Report Name	Fully Bioresorbable Stents Market
Segment by Type	Below 100μm 100-150μm More than 150μm
Segment by Application	Hospital Surgical Centers Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott, Lepu Medical Technology, Shandong Hua'an Biotechnology, MicroPort, Lifetech Scientific, Beijing Advanced Medical Technologies, Shanghai Bio-heart Biological Technology, Elixir Medical Corporation, Biotronic
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fully Bioresorbable Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fully Bioresorbable Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Fully Bioresorbable Stents Market report?

Ans: The main players in the Fully Bioresorbable Stents Market are Abbott, Lepu Medical Technology, Shandong Hua'an Biotechnology, MicroPort, Lifetech Scientific, Beijing Advanced Medical Technologies, Shanghai Bio-heart Biological Technology, Elixir Medical Corporation, Biotronic

What are the Application segmentation covered in the Fully Bioresorbable Stents Market report?

Ans: The Applications covered in the Fully Bioresorbable Stents Market report are Hospital, Surgical Centers, Others

What are the Type segmentation covered in the Fully Bioresorbable Stents Market report?

Ans: The Types covered in the Fully Bioresorbable Stents Market report are Below 100μm, 100-150μm, More than 150μm

1 Fully Bioresorbable Stents Market Overview

1.1 Product Definition

1.2 Fully Bioresorbable Stents by Type

1.2.1 Global Fully Bioresorbable Stents Market Value Comparison by Type (2024 VS 2031)

1.2.2 Below 100μm

1.2.3 100-150μm

1.2.4 More than 150μm

1.3 Fully Bioresorbable Stents by Application

1.3.1 Global Fully Bioresorbable Stents Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Surgical Centers

1.3.4 Others

1.4 Global Fully Bioresorbable Stents Market Size Estimates and Forecasts

1.4.1 Global Fully Bioresorbable Stents Revenue 2020-2031

1.4.2 Global Fully Bioresorbable Stents Sales 2020-2031

1.4.3 Global Fully Bioresorbable Stents Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Fully Bioresorbable Stents Market Competition by Manufacturers

2.1 Global Fully Bioresorbable Stents Sales Market Share by Manufacturers (2020-2025)

2.2 Global Fully Bioresorbable Stents Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Fully Bioresorbable Stents Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Fully Bioresorbable Stents, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Fully Bioresorbable Stents, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Fully Bioresorbable Stents, Product Type & Application

2.7 Global Key Manufacturers of Fully Bioresorbable Stents, Date of Enter into This Industry

2.8 Global Fully Bioresorbable Stents Market Competitive Situation and Trends

2.8.1 Global Fully Bioresorbable Stents Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Fully Bioresorbable Stents Players Market Share by Revenue

2.8.3 Global Fully Bioresorbable Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Fully Bioresorbable Stents Market Scenario by Region

3.1 Global Fully Bioresorbable Stents Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Fully Bioresorbable Stents Sales by Region: 2020-2031

3.2.1 Global Fully Bioresorbable Stents Sales by Region: 2020-2025

3.2.2 Global Fully Bioresorbable Stents Sales by Region: 2026-2031

3.3 Global Fully Bioresorbable Stents Revenue by Region: 2020-2031

3.3.1 Global Fully Bioresorbable Stents Revenue by Region: 2020-2025

3.3.2 Global Fully Bioresorbable Stents Revenue by Region: 2026-2031

3.4 North America Fully Bioresorbable Stents Market Facts & Figures by Country

3.4.1 North America Fully Bioresorbable Stents Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Fully Bioresorbable Stents Sales by Country (2020-2031)

3.4.3 North America Fully Bioresorbable Stents Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Fully Bioresorbable Stents Market Facts & Figures by Country

3.5.1 Europe Fully Bioresorbable Stents Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Fully Bioresorbable Stents Sales by Country (2020-2031)

3.5.3 Europe Fully Bioresorbable Stents Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Fully Bioresorbable Stents Market Facts & Figures by Region

3.6.1 Asia Pacific Fully Bioresorbable Stents Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Fully Bioresorbable Stents Sales by Region (2020-2031)

3.6.3 Asia Pacific Fully Bioresorbable Stents Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Fully Bioresorbable Stents Market Facts & Figures by Country

3.7.1 Latin America Fully Bioresorbable Stents Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Fully Bioresorbable Stents Sales by Country (2020-2031)

3.7.3 Latin America Fully Bioresorbable Stents Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Fully Bioresorbable Stents Market Facts & Figures by Country

3.8.1 Middle East and Africa Fully Bioresorbable Stents Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Fully Bioresorbable Stents Sales by Country (2020-2031)

3.8.3 Middle East and Africa Fully Bioresorbable Stents Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Fully Bioresorbable Stents Sales by Type (2020-2031)

4.1.1 Global Fully Bioresorbable Stents Sales by Type (2020-2025)

4.1.2 Global Fully Bioresorbable Stents Sales by Type (2026-2031)

4.1.3 Global Fully Bioresorbable Stents Sales Market Share by Type (2020-2031)

4.2 Global Fully Bioresorbable Stents Revenue by Type (2020-2031)

4.2.1 Global Fully Bioresorbable Stents Revenue by Type (2020-2025)

4.2.2 Global Fully Bioresorbable Stents Revenue by Type (2026-2031)

4.2.3 Global Fully Bioresorbable Stents Revenue Market Share by Type (2020-2031)

4.3 Global Fully Bioresorbable Stents Price by Type (2020-2031)

5 Segment by Application

5.1 Global Fully Bioresorbable Stents Sales by Application (2020-2031)

5.1.1 Global Fully Bioresorbable Stents Sales by Application (2020-2025)

5.1.2 Global Fully Bioresorbable Stents Sales by Application (2026-2031)

5.1.3 Global Fully Bioresorbable Stents Sales Market Share by Application (2020-2031)

5.2 Global Fully Bioresorbable Stents Revenue by Application (2020-2031)

5.2.1 Global Fully Bioresorbable Stents Revenue by Application (2020-2025)

5.2.2 Global Fully Bioresorbable Stents Revenue by Application (2026-2031)

5.2.3 Global Fully Bioresorbable Stents Revenue Market Share by Application (2020-2031)

5.3 Global Fully Bioresorbable Stents Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Abbott

6.1.1 Abbott Company Information

6.1.2 Abbott Description and Business Overview

6.1.3 Abbott Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Abbott Fully Bioresorbable Stents Product Portfolio

6.1.5 Abbott Recent Developments/Updates

6.2 Lepu Medical Technology

6.2.1 Lepu Medical Technology Company Information

6.2.2 Lepu Medical Technology Description and Business Overview

6.2.3 Lepu Medical Technology Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Lepu Medical Technology Fully Bioresorbable Stents Product Portfolio

6.2.5 Lepu Medical Technology Recent Developments/Updates

6.3 Shandong Hua'an Biotechnology

6.3.1 Shandong Hua'an Biotechnology Company Information

6.3.2 Shandong Hua'an Biotechnology Description and Business Overview

6.3.3 Shandong Hua'an Biotechnology Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Shandong Hua'an Biotechnology Fully Bioresorbable Stents Product Portfolio

6.3.5 Shandong Hua'an Biotechnology Recent Developments/Updates

6.4 MicroPort

6.4.1 MicroPort Company Information

6.4.2 MicroPort Description and Business Overview

6.4.3 MicroPort Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2020-2025)

6.4.4 MicroPort Fully Bioresorbable Stents Product Portfolio

6.4.5 MicroPort Recent Developments/Updates

6.5 Lifetech Scientific

6.5.1 Lifetech Scientific Company Information

6.5.2 Lifetech Scientific Description and Business Overview

6.5.3 Lifetech Scientific Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Lifetech Scientific Fully Bioresorbable Stents Product Portfolio

6.5.5 Lifetech Scientific Recent Developments/Updates

6.6 Beijing Advanced Medical Technologies

6.6.1 Beijing Advanced Medical Technologies Company Information

6.6.2 Beijing Advanced Medical Technologies Description and Business Overview

6.6.3 Beijing Advanced Medical Technologies Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Beijing Advanced Medical Technologies Fully Bioresorbable Stents Product Portfolio

6.6.5 Beijing Advanced Medical Technologies Recent Developments/Updates

6.7 Shanghai Bio-heart Biological Technology

6.7.1 Shanghai Bio-heart Biological Technology Company Information

6.7.2 Shanghai Bio-heart Biological Technology Description and Business Overview

6.7.3 Shanghai Bio-heart Biological Technology Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Shanghai Bio-heart Biological Technology Fully Bioresorbable Stents Product Portfolio

6.7.5 Shanghai Bio-heart Biological Technology Recent Developments/Updates

6.8 Elixir Medical Corporation

6.8.1 Elixir Medical Corporation Company Information

6.8.2 Elixir Medical Corporation Description and Business Overview

6.8.3 Elixir Medical Corporation Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Elixir Medical Corporation Fully Bioresorbable Stents Product Portfolio

6.8.5 Elixir Medical Corporation Recent Developments/Updates

6.9 Biotronic

6.9.1 Biotronic Company Information

6.9.2 Biotronic Description and Business Overview

6.9.3 Biotronic Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Biotronic Fully Bioresorbable Stents Product Portfolio

6.9.5 Biotronic Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Fully Bioresorbable Stents Industry Chain Analysis

7.2 Fully Bioresorbable Stents Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Fully Bioresorbable Stents Production Mode & Process Analysis

7.4 Fully Bioresorbable Stents Sales and Marketing

7.4.1 Fully Bioresorbable Stents Sales Channels

7.4.2 Fully Bioresorbable Stents Distributors

7.5 Fully Bioresorbable Stents Customer Analysis

8 Fully Bioresorbable Stents Market Dynamics

8.1 Fully Bioresorbable Stents Industry Trends

8.2 Fully Bioresorbable Stents Market Drivers

8.3 Fully Bioresorbable Stents Market Challenges

8.4 Fully Bioresorbable Stents Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Abbott

Lepu Medical Technology

Shandong Hua'an Biotechnology

MicroPort

LifeTech Scientific

Beijing Advanced Medical Technologies

Shanghai Bio-heart Biological Technology

Elixir Medical Corporation

Biotronic

List of Tables

Table 1. Global Fully Bioresorbable Stents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Fully Bioresorbable Stents Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Fully Bioresorbable Stents Market Competitive Situation by Manufacturers in 2024

Table 4. Global Fully Bioresorbable Stents Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Fully Bioresorbable Stents Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Fully Bioresorbable Stents Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Fully Bioresorbable Stents Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Fully Bioresorbable Stents Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Fully Bioresorbable Stents, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Fully Bioresorbable Stents, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Fully Bioresorbable Stents, Product Type & Application

Table 12. Global Key Manufacturers of Fully Bioresorbable Stents, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Fully Bioresorbable Stents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fully Bioresorbable Stents as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Fully Bioresorbable Stents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Fully Bioresorbable Stents Sales by Region (2020-2025) & (K Units)

Table 18. Global Fully Bioresorbable Stents Sales Market Share by Region (2020-2025)

Table 19. Global Fully Bioresorbable Stents Sales by Region (2026-2031) & (K Units)

Table 20. Global Fully Bioresorbable Stents Sales Market Share by Region (2026-2031)

Table 21. Global Fully Bioresorbable Stents Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Fully Bioresorbable Stents Revenue Market Share by Region (2020-2025)

Table 23. Global Fully Bioresorbable Stents Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Fully Bioresorbable Stents Revenue Market Share by Region (2026-2031)

Table 25. North America Fully Bioresorbable Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Fully Bioresorbable Stents Sales by Country (2020-2025) & (K Units)

Table 27. North America Fully Bioresorbable Stents Sales by Country (2026-2031) & (K Units)

Table 28. North America Fully Bioresorbable Stents Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Fully Bioresorbable Stents Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Fully Bioresorbable Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Fully Bioresorbable Stents Sales by Country (2020-2025) & (K Units)

Table 32. Europe Fully Bioresorbable Stents Sales by Country (2026-2031) & (K Units)

Table 33. Europe Fully Bioresorbable Stents Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Fully Bioresorbable Stents Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Fully Bioresorbable Stents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Fully Bioresorbable Stents Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Fully Bioresorbable Stents Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Fully Bioresorbable Stents Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Fully Bioresorbable Stents Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Fully Bioresorbable Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Fully Bioresorbable Stents Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Fully Bioresorbable Stents Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Fully Bioresorbable Stents Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Fully Bioresorbable Stents Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Fully Bioresorbable Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Fully Bioresorbable Stents Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Fully Bioresorbable Stents Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Fully Bioresorbable Stents Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Fully Bioresorbable Stents Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Fully Bioresorbable Stents Sales (K Units) by Type (2020-2025)

Table 51. Global Fully Bioresorbable Stents Sales (K Units) by Type (2026-2031)

Table 52. Global Fully Bioresorbable Stents Sales Market Share by Type (2020-2025)

Table 53. Global Fully Bioresorbable Stents Sales Market Share by Type (2026-2031)

Table 54. Global Fully Bioresorbable Stents Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Fully Bioresorbable Stents Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Fully Bioresorbable Stents Revenue Market Share by Type (2020-2025)

Table 57. Global Fully Bioresorbable Stents Revenue Market Share by Type (2026-2031)

Table 58. Global Fully Bioresorbable Stents Price (US$/Unit) by Type (2020-2025)

Table 59. Global Fully Bioresorbable Stents Price (US$/Unit) by Type (2026-2031)

Table 60. Global Fully Bioresorbable Stents Sales (K Units) by Application (2020-2025)

Table 61. Global Fully Bioresorbable Stents Sales (K Units) by Application (2026-2031)

Table 62. Global Fully Bioresorbable Stents Sales Market Share by Application (2020-2025)

Table 63. Global Fully Bioresorbable Stents Sales Market Share by Application (2026-2031)

Table 64. Global Fully Bioresorbable Stents Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Fully Bioresorbable Stents Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Fully Bioresorbable Stents Revenue Market Share by Application (2020-2025)

Table 67. Global Fully Bioresorbable Stents Revenue Market Share by Application (2026-2031)

Table 68. Global Fully Bioresorbable Stents Price (US$/Unit) by Application (2020-2025)

Table 69. Global Fully Bioresorbable Stents Price (US$/Unit) by Application (2026-2031)

Table 70. Abbott Company Information

Table 71. Abbott Description and Business Overview

Table 72. Abbott Fully Bioresorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Abbott Fully Bioresorbable Stents Product

Table 74. Abbott Recent Developments/Updates

Table 75. Lepu Medical Technology Company Information

Table 76. Lepu Medical Technology Description and Business Overview

Table 77. Lepu Medical Technology Fully Bioresorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Lepu Medical Technology Fully Bioresorbable Stents Product

Table 79. Lepu Medical Technology Recent Developments/Updates

Table 80. Shandong Hua'an Biotechnology Company Information

Table 81. Shandong Hua'an Biotechnology Description and Business Overview

Table 82. Shandong Hua'an Biotechnology Fully Bioresorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Shandong Hua'an Biotechnology Fully Bioresorbable Stents Product

Table 84. Shandong Hua'an Biotechnology Recent Developments/Updates

Table 85. MicroPort Company Information

Table 86. MicroPort Description and Business Overview

Table 87. MicroPort Fully Bioresorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. MicroPort Fully Bioresorbable Stents Product

Table 89. MicroPort Recent Developments/Updates

Table 90. Lifetech Scientific Company Information

Table 91. Lifetech Scientific Description and Business Overview

Table 92. Lifetech Scientific Fully Bioresorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Lifetech Scientific Fully Bioresorbable Stents Product

Table 94. Lifetech Scientific Recent Developments/Updates

Table 95. Beijing Advanced Medical Technologies Company Information

Table 96. Beijing Advanced Medical Technologies Description and Business Overview

Table 97. Beijing Advanced Medical Technologies Fully Bioresorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Beijing Advanced Medical Technologies Fully Bioresorbable Stents Product

Table 99. Beijing Advanced Medical Technologies Recent Developments/Updates

Table 100. Shanghai Bio-heart Biological Technology Company Information

Table 101. Shanghai Bio-heart Biological Technology Description and Business Overview

Table 102. Shanghai Bio-heart Biological Technology Fully Bioresorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Shanghai Bio-heart Biological Technology Fully Bioresorbable Stents Product

Table 104. Shanghai Bio-heart Biological Technology Recent Developments/Updates

Table 105. Elixir Medical Corporation Company Information

Table 106. Elixir Medical Corporation Description and Business Overview

Table 107. Elixir Medical Corporation Fully Bioresorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Elixir Medical Corporation Fully Bioresorbable Stents Product

Table 109. Elixir Medical Corporation Recent Developments/Updates

Table 110. Biotronic Company Information

Table 111. Biotronic Description and Business Overview

Table 112. Biotronic Fully Bioresorbable Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Biotronic Fully Bioresorbable Stents Product

Table 114. Biotronic Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Fully Bioresorbable Stents Distributors List

Table 118. Fully Bioresorbable Stents Customers List

Table 119. Fully Bioresorbable Stents Market Trends

Table 120. Fully Bioresorbable Stents Market Drivers

Table 121. Fully Bioresorbable Stents Market Challenges

Table 122. Fully Bioresorbable Stents Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Fully Bioresorbable Stents

Figure 2. Global Fully Bioresorbable Stents Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Fully Bioresorbable Stents Market Share by Type: 2024 & 2031

Figure 4. Below 100μm Product Picture

Figure 5. 100-150μm Product Picture

Figure 6. More than 150μm Product Picture

Figure 7. Global Fully Bioresorbable Stents Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Fully Bioresorbable Stents Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Surgical Centers

Figure 11. Others

Figure 12. Global Fully Bioresorbable Stents Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Fully Bioresorbable Stents Market Size (2020-2031) & (US$ Million)

Figure 14. Global Fully Bioresorbable Stents Sales (2020-2031) & (K Units)

Figure 15. Global Fully Bioresorbable Stents Average Price (US$/Unit) & (2020-2031)

Figure 16. Fully Bioresorbable Stents Report Years Considered

Figure 17. Fully Bioresorbable Stents Sales Share by Manufacturers in 2024

Figure 18. Global Fully Bioresorbable Stents Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Fully Bioresorbable Stents Players: Market Share by Revenue in Fully Bioresorbable Stents in 2024

Figure 20. Fully Bioresorbable Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Fully Bioresorbable Stents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Fully Bioresorbable Stents Sales Market Share by Country (2020-2031)

Figure 23. North America Fully Bioresorbable Stents Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Fully Bioresorbable Stents Sales Market Share by Country (2020-2031)

Figure 27. Europe Fully Bioresorbable Stents Revenue Market Share by Country (2020-2031)

Figure 28. Germany Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Fully Bioresorbable Stents Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Fully Bioresorbable Stents Revenue Market Share by Region (2020-2031)

Figure 35. China Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Fully Bioresorbable Stents Sales Market Share by Country (2020-2031)

Figure 46. Latin America Fully Bioresorbable Stents Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Fully Bioresorbable Stents Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Fully Bioresorbable Stents Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Fully Bioresorbable Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Fully Bioresorbable Stents by Type (2020-2031)

Figure 56. Global Revenue Market Share of Fully Bioresorbable Stents by Type (2020-2031)

Figure 57. Global Fully Bioresorbable Stents Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Fully Bioresorbable Stents by Application (2020-2031)

Figure 59. Global Revenue Market Share of Fully Bioresorbable Stents by Application (2020-2031)

Figure 60. Global Fully Bioresorbable Stents Price (US$/Unit) by Application (2020-2031)

Figure 61. Fully Bioresorbable Stents Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions